Holen Sie sich die Stockscreener-App
116.15
1.04%
1.20
Handel nachbörslich:
115.90
-0.25
-0.22%
Schlusskurs vom Vortag:
$114.95
Offen:
$114
24-Stunden-Volumen:
1.29M
Relative Volume:
0.68
Marktkapitalisierung:
$10.13B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-386.19M
KGV:
-22.10
EPS:
-5.2547
Netto-Cashflow:
$-206.27M
1W Leistung:
-3.79%
1M Leistung:
-7.60%
6M Leistung:
-9.46%
1J Leistung:
+50.30%
1-Tages-Spanne:
$113.29
$116.22
1-Wochen-Bereich:
$113.29
$121.25
52-Wochen-Spanne:
$69.81
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
116.15 | 10.31B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Eingeleitet | Jefferies | Buy |
| 2026-02-24 | Eingeleitet | Wedbush | Outperform |
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-06 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-07-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-12-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | Laidlaw | Buy |
| 2024-05-20 | Eingeleitet | BTIG Research | Buy |
| 2024-04-29 | Eingeleitet | Guggenheim | Buy |
| 2024-04-29 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-14 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Abivax Adr Aktie (ABVX) Neueste Nachrichten
Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada - MarketBeat
Bank of America Corp DE Purchases 213,440 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Militia Capital Management LLC Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Perceptive Advisors LLC Cuts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC - MarketBeat
Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – FWB:2X10 - TradingView
Ally Bridge Group NY LLC Lowers Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Eversept Partners LP Has $104.05 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Octagon Capital Advisors LP - MarketBeat
Orbimed Advisors LLC Has $51.86 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Hsbc Holdings PLC Has $1.71 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance UK
ABIVAX Société Anonyme (ABVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Caxton Associates LLP Acquires Shares of 24,750 Abivax SA Sponsored ADR $ABVX - MarketBeat
Affinity Asset Advisors LLC Has $45.10 Million Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – SWB:2X10 - TradingView
Abivax SA Sponsored ADR $ABVX Position Increased by PSquared Asset Management AG - MarketBeat
Atika Capital Management LLC Sells 26,200 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
17,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Militia Capital Management LLC - MarketBeat
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
Abivax SA Sponsored ADR $ABVX Shares Bought by Jennison Associates LLC - MarketBeat
Principal Financial Group Inc. Increases Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Should you buy Abivax SA sponsored ADR (ABVX) after golden cross? - MSN
Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross? - Yahoo Finance
3 Soaring Stocks That May Have More Upside Ahead - The Motley Fool
2X10 Forecast — Price Target — Prediction for 2027 - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Why Abivax’s Hot Rally Is Suddenly Cooling Off - TipRanks
Weekly Recap: Upsized $920M ADS offering and Obefazimod UC results - TradingView
Pictet Asset Management Holding SA Reduces Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Abivax SA Raises $760 Million in Major U.S. ADS Offering - TipRanks
Abivax Slides As Massive Stock Offering Spooks Traders - TipRanks
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Abivax SA Sponsored ADR (ABVX) and Larimar Therapeutics (LRMR) - The Globe and Mail
Why is Abivax stock climbing today? - Investing.com UK
Abivax stock surges on Phase 3 ulcerative colitis data By Investing.com - Investing.com Nigeria
Abivax Posts Positive Phase 3 Maintenance Data for Obefazimod in Refractory Ulcerative Colitis - TipRanks
Finanzdaten der Abivax Adr-Aktie (ABVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
3.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):